Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-13 to 2022-05-04
Current total value of award: $1918.5
Description: 4557078979!ZOLADEX 3.6 MG IMPLANT SYRNS